Phospholipase D1 is upregulated by vorinostat and confers resistance to vorinostat in glioblastoma

Glioblastoma (GBM) is an aggressive brain tumor and drug resistance remains a major barrier for therapeutics. Epigenetic alterations are implicated in GBM pathogenesis, and epigenetic modulators including histone deacetylase (HDAC) inhibitors are exploited as promising anticancer therapies. Here, we...

Descripción completa

Detalles Bibliográficos
Autores principales: Kang, Dong Woo, Hwang, Won Chan, Noh, Yu Na, Kang, Youra, Jang, Younghoon, Kim, Jung‐Ae, Min, Do Sik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7692931/
https://www.ncbi.nlm.nih.gov/pubmed/32869317
http://dx.doi.org/10.1002/jcp.29882

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7692931/
https://www.ncbi.nlm.nih.gov/pubmed/32869317
http://dx.doi.org/10.1002/jcp.29882

Ejemplares similares